Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group.
Yamashita S, Takeshima H, Hata N, Uchida H, Shinojima N, Yokogami K, Nakano Y, Sakata K, Fudaba H, Enomoto T, Nakahara Y, Ujifuku K, Sugawara K, Iwaki T, Sangatsuda Y, Yoshimoto K, Hanaya R, Mukasa A, Suzuki K, Yamamoto J, Negoto T, Nakamura H, Momii Y, Fujiki M, Abe H, Masuoka J, Abe T, Matsuo T, Ishiuchi S; Kyushu Neuro-Oncology Study Group. Yamashita S, et al. Among authors: uchida h. J Neurooncol. 2023 Apr;162(2):425-433. doi: 10.1007/s11060-023-04310-w. Epub 2023 Apr 13. J Neurooncol. 2023. PMID: 37052748
A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.
Higa N, Akahane T, Yokoyama S, Yonezawa H, Uchida H, Takajo T, Kirishima M, Hamada T, Matsuo K, Fujio S, Hanada T, Hosoyama H, Yonenaga M, Sakamoto A, Hiraki T, Tanimoto A, Yoshimoto K. Higa N, et al. Among authors: uchida h. Cancer Sci. 2020 Oct;111(10):3902-3911. doi: 10.1111/cas.14597. Epub 2020 Sep 6. Cancer Sci. 2020. PMID: 32748499 Free PMC article.
Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma.
Yamamoto M, Sanomachi T, Suzuki S, Uchida H, Yonezawa H, Higa N, Takajo T, Yamada Y, Sugai A, Togashi K, Seino S, Okada M, Sonoda Y, Hirano H, Yoshimoto K, Kitanaka C. Yamamoto M, et al. Among authors: uchida h. Neuro Oncol. 2021 Jun 1;23(6):945-954. doi: 10.1093/neuonc/noab015. Neuro Oncol. 2021. PMID: 33556172 Free PMC article.
Integrated diagnosis of adult-type glioma according to 2021 World Health Organization classification: Analysis of 184 cases using a custom-made next-generation sequencing panel.
Kirishima M, Akahane T, Higa N, Yonezawa H, Uchida H, Kitazono I, Higashi M, Yoshimoto K, Tanimoto A. Kirishima M, et al. Among authors: uchida h. Pathol Int. 2022 Mar;72(3):207-210. doi: 10.1111/pin.13197. Epub 2022 Jan 19. Pathol Int. 2022. PMID: 35044022 No abstract available.
Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma.
Higa N, Akahane T, Yokoyama S, Yonezawa H, Uchida H, Takajo T, Otsuji R, Hamada T, Matsuo K, Kirishima M, Hata N, Hanaya R, Tanimoto A, Yoshimoto K. Higa N, et al. Among authors: uchida h. Neurooncol Adv. 2022 Jun 21;4(1):vdac097. doi: 10.1093/noajnl/vdac097. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35911637 Free PMC article.
2,371 results